Squarepoint Ops LLC Landec Corp \Ca\ Transaction History

Squarepoint Ops LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	N/A	23,657 New	23,657 $0
Q4 2022 Feb 14, 2023	BUY	$0.0 - $9.95 $0 - $177,000	17,789 New	17,789 $0
Q1 2022 May 16, 2022	SELL	$10.07 - $11.93 $154,564 - $183,113	-15,349 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$7.95 - $11.24 $233,483 - $330,107	-29,369 Reduced 65.68%	15,349 $170,000
Q3 2021 Nov 15, 2021	BUY	$9.22 - $12.44 $32,500 - $43,851	3,525 Added 8.56%	44,718 $412,000
Q2 2021 Aug 16, 2021	BUY	$9.91 - $12.78 $182,383 - $235,203	18,404 Added 80.76%	41,193 $463,000
Q1 2021 May 17, 2021	SELL	$10.44 - $12.22 $654,389 - $765,961	-62,681 Reduced 73.34%	22,789 $242,000
Q4 2020 Feb 16, 2021	BUY	$9.3 - $11.77 $242,032 - $306,314	26,025 Added 43.78%	85,470 $927,000
Q3 2020 Nov 16, 2020	BUY	$7.59 - $10.8 $451,187 - $642,006	59,445 New	59,445 $578,000
Q1 2020 May 15, 2020	SELL	$7.69 - $11.68 $144,064 - $218,813	-18,734 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$9.09 - $11.89 $118,569 - $155,093	-13,044 Reduced 41.05%	18,734 $212,000
Q3 2019 Nov 14, 2019	BUY	$9.66 - $12.36 $306,975 - $392,776	31,778 New	31,778 $345,000

20.3M

79.7K

31.6K

Ticker LNDC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,595,600
Description
Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.